1-9 of 9
Monica T Hinds
Close
Sort by
Journal Articles

Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Cancer Patients Undergoing Central Line Placement: A Phase 2 Clinical Trial

Michael A Pfeffer, Helen Vu, Tia CL Kohs, Jenny Wang, Christina U Lorentz, Erik I Tucker, Sven R Olson, Thomas G Deloughery, Monica T Hinds, Owen JT McCarty, Joseph J Shatzel
Journal: Blood
Blood (2022) 140 (Supplement 1): 1247–1249.
https://doi.org/10.1182/blood-2022-170429
Published: 2022
Journal Articles

Antiplatelet Effects of Inhibiting Coagulation Factor XI in a Diet-Induced Obesity Model of Early Atherosclerosis

Tia CL Kohs, Iván Parra-Izquierdo, Helen Vu, Monica T Hinds, Joseph J Shatzel, Joseph E Aslan, Michael Wallisch, Erik I Tucker, Christina U Lorentz, Cristina Puy, David Gailani, Owen JT McCarty
Journal: Blood
Blood (2022) 140 (Supplement 1): 8437.
https://doi.org/10.1182/blood-2022-170472
Published: 2022
Journal Articles

The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial

Clinical Trials & Observations
Christina U. Lorentz, Erik I. Tucker, Norah G. Verbout, Joseph J. Shatzel, Sven R. Olson, Brandon D. Markway, Michael Wallisch, Martina Ralle, Monica T. Hinds, Owen J. T. McCarty, David Gailani, Jeffrey I. Weitz, András Gruber
Journal: Blood
Blood (2021) 138 (22): 2173–2184.
https://doi.org/10.1182/blood.2021011725
Published: 2021
Includes: Supplemental data
Journal Articles

Abelacimab Reduces Thrombus Propagation in a Baboon Model of Vascular Graft Thrombosis

Michael Wallisch, Yasser Khder, Monica T. Hinds, Erik I Tucker, Dan Bloomfield, Andras Gruber
Journal: Blood
Blood (2021) 138 (Supplement 1): 1027.
https://doi.org/10.1182/blood-2021-150535
Published: 2021
Journal Articles

Safety and Efficacy of the Contact Activation Inhibitor AB023 in Patients with End-Stage Renal Disease on Chronic Hemodialysis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial

Christina U Lorentz, PhD, Norah G Verbout, PhD, Joseph J Shatzel, MD, Michael Wallisch, PhD, Brandon D Markway, PhD, Monica T Hinds, PhD, Owen J T McCarty, PhD, David Gailani, MD, Jeffrey I. Weitz, MDFRCPC, Erik I Tucker, PhD, András Gruber, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-139948
Published: 2020
Journal Articles

The protein C activator AB002 rapidly interrupts thrombus development in baboons

Clinical Trials & Observations
Erik I. Tucker, Norah G. Verbout, Brandon D. Markway, Michael Wallisch, Christina U. Lorentz, Monica T. Hinds, Joseph J. Shatzel, Leslie A. Pelc, David C. Wood, Owen J. T. McCarty, Enrico Di Cera, András Gruber
Journal: Blood
Blood (2020) 135 (9): 689–699.
https://doi.org/10.1182/blood.2019002771
Published: 2020
Includes: Supplemental data
Journal Articles

The Anti-Factor XII Antibody AB052 Is Antithrombotic without Hemostatic Impairment in a Primate Model of Extracorporeal Membrane Oxygenation

Michael Wallisch, PhD, Erik I Tucker, PhD, Christina U Lorentz, PhD, Jennifer Johnson, RLATG, Marschelle R Carris, BA, Owen JT McCarty, PhD, Monica T Hinds, PhD, András Gruber, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 236.
https://doi.org/10.1182/blood.V130.Suppl_1.236.236
Published: 2017
Journal Articles

Lack of Substantial Antithrombotic Effect of Low Circulating Coagulation Factor VII Levels in a Baboon Model of Acute Vascular Graft Thrombosis

Michael Wallisch, PhD, Greisel Jennifer, BS, Erik I Tucker, PhD, Owen J.T. McCarty, PhD, Monica T Hinds, PhD, Sue Murray, Jeff Crosby, PhD, Brett P. Monia, PhD, Andras Gruber, MD
Journal: Blood
Blood (2014) 124 (21): 1485.
https://doi.org/10.1182/blood.V124.21.1485.1485
Published: 2014
Journal Articles

Endothelial Cell Elongation Impacts Thrombogenicity Independent of Fluid Shear Stress.

Keri B Vartanian, Brad J Blakley, Owen JT McCarty, PhD, Stephen Hanson, PhD, Monica T Hinds, PhD
Journal: Blood
Blood (2008) 112 (11): 1886.
https://doi.org/10.1182/blood.V112.11.1886.1886
Published: 2008